Phenytoin has been considered a possible cause of cerbellar degenerati
on, especially after clinical intoxication. Magnetic resonance provide
s the diagnosis of anatomical structures in the posterior fossa withou
t the limitation of beam hardening artefacts. The aim of this study wa
s to evaluate the relationship of phenytoin medication and cerebellar
atrophy in 11 patients with increased serum levels (21.4 mug/ml-95.6 m
ug/ml). Five patients had normal cerebellar structures, although three
of them had a history of clinical intoxication and all had at least o
ne episode of increased serum level of DPH. The remaining six patients
had moderate severe cerebellar atrophy (n = 4) and atrophy of the ver
mis cerebelli (n = 5). Two of them had never experienced clinical into
xication. There was no correlation between the degree of atrophy and s
everity of clinical symptoms and evaluation of serum DPH levels (up to
four times normal values). There was also no correlation between cere
bellar atrophy, duration of epilepsy and frequency of seizures. We con
clude that phenytoin overdosage does not necessarily result in cerebel
lar atrophy and it is unlikely that phenytoin medication was the only
cause of cerebellar atrophy in the remaining patients.